Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Jilma

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
European Journal of Haematology|October 26, 1999
The proportion of reticulated platelets is higher in bone marrow than in peripheral blood in haematological patientsP Stohlawetz, A Schulenburg, G Stiegler, et al.
Journal of Thrombosis and Haemostasis : JTH|February 4, 2009
Racial differences in endotoxin-induced tissue factor-triggered coagulationF B Mayr, A O Spiel, J M Leitner, et al.
Lancet (London, England)|December 7, 2007
Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trialE Tauber, H Kollaritsch, M Korinek, et al.
Journal of Thrombosis and Haemostasis : JTH|December 9, 2015
Comparison between the impact of morning and evening doses of rivaroxaban on the circadian endogenous coagulation rhythm in healthy subjectsS Brunner-Ziegler, B Jilma, C Schörgenhofer, et al.
British Journal of Haematology|February 13, 2001
High levels of reticulated platelets and thrombopoietin characterize fetal thrombopoiesisP Jilma-Stohlawetz, M Homoncik, B Jilma, et al.
Clinical Pharmacology and Therapeutics|April 6, 2007
Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulationJ M Leitner, B Jilma, F B Mayr, et al.
Journal of Thrombosis and Haemostasis : JTH|January 21, 2012
Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI studyJ M Siller-Matula, G Delle-Karth, I M Lang, et al.
Thrombosis Research|November 5, 1997
Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settingsK Ruzicka, S Kapiotis, P Quehenberger, et al.
Scientific Reports|December 14, 2019
Comparative proteomics reveals unexpected quantitative phosphorylation differences linked to platelet activation stateG J Schmidt, C M Reumiller, H Ercan, et al.
Human Reproduction (Oxford, England)|August 29, 2014
A first-in-human study of PDC31 (prostaglandin F2α receptor inhibitor) in primary dysmenorrheaB Böttcher, R M Laterza, L Wildt, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
European Journal of Haematology|October 26, 1999
The proportion of reticulated platelets is higher in bone marrow than in peripheral blood in haematological patientsP Stohlawetz, A Schulenburg, G Stiegler, et al.
Journal of Thrombosis and Haemostasis : JTH|February 4, 2009
Racial differences in endotoxin-induced tissue factor-triggered coagulationF B Mayr, A O Spiel, J M Leitner, et al.
Lancet (London, England)|December 7, 2007
Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trialE Tauber, H Kollaritsch, M Korinek, et al.
Journal of Thrombosis and Haemostasis : JTH|December 9, 2015
Comparison between the impact of morning and evening doses of rivaroxaban on the circadian endogenous coagulation rhythm in healthy subjectsS Brunner-Ziegler, B Jilma, C Schörgenhofer, et al.
British Journal of Haematology|February 13, 2001
High levels of reticulated platelets and thrombopoietin characterize fetal thrombopoiesisP Jilma-Stohlawetz, M Homoncik, B Jilma, et al.
Clinical Pharmacology and Therapeutics|April 6, 2007
Pharmacokinetics and pharmacodynamics of the dual FII/FX inhibitor BIBT 986 in endotoxin-induced coagulationJ M Leitner, B Jilma, F B Mayr, et al.
Journal of Thrombosis and Haemostasis : JTH|January 21, 2012
Phenotyping vs. genotyping for prediction of clopidogrel efficacy and safety: the PEGASUS-PCI studyJ M Siller-Matula, G Delle-Karth, I M Lang, et al.
Thrombosis Research|November 5, 1997
Evaluation of bedside prothrombin time and activated partial thromboplastin time measurement by coagulation analyzer CoaguCheck Plus in various clinical settingsK Ruzicka, S Kapiotis, P Quehenberger, et al.
Scientific Reports|December 14, 2019
Comparative proteomics reveals unexpected quantitative phosphorylation differences linked to platelet activation stateG J Schmidt, C M Reumiller, H Ercan, et al.
Human Reproduction (Oxford, England)|August 29, 2014
A first-in-human study of PDC31 (prostaglandin F2α receptor inhibitor) in primary dysmenorrheaB Böttcher, R M Laterza, L Wildt, et al.
Pageof 14